Hotel owners and property developers remain confident in industry's resiliency despite a news cycle dominated by tariffs, inflation, interest rates and more PARSIPPANY, N.J. , June 2, 2025 /PRNewswire/ -- Wyndham Hotels & Resorts today unveiled its first-annual Hotel Owner Trends Report.

CHEVY CHASE, Md. , June 2, 2025 /PRNewswire/ -- FCP® has closed on a $13.25 million preferred equity investment through its Structured Investments platform to finance Mosaic Pooler , a 333-unit, Class A multifamily development on Old Quacco Road in the dynamic Savannah submarket of Pooler, GA.

Marriott bolsters industry's largest residential portfolio with several signed agreements in desirable destinations around the world. NEW YORK , June 2, 2025 /PRNewswire/ -- Today, Marriott International, Inc. (Nasdaq: MAR), the industry leader in branded residential development, announces signed agreements in: Detroit, Michigan ; Muskoka, Canada; Gulf of Papagayo, Guanacaste, Costa Rica; and Jeddah, Saudi Arabia ; bringing the Marriott Branded Residences total open and pipeline portfolio to around 300 projects.

News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas, and occupies up to 50% less bench space than other products in its class.2 Takes the industry-leading sensitivity of Xevo TQ Absolute to new heights, including for PFAS detection and pharma quantitation applications. BALTIMORE and MILFORD, Mass.

Spanish service provider transforms key processes to enhance business agility and service delivery with Oracle Communications and Optare Solutions AUSTIN, Texas and MADRID , June 2, 2025 /PRNewswire/ -- Lyntia Networks, a leading neutral operator in the wholesale telecom sector, is relying on Oracle solutions to help meet its ambitious growth in the highly competitive infrastructure and connectivity markets. The operator is leveraging the out-of-the-box capabilities of Oracle Communications cloud native solutions to transform its operational support systems (OSS), enabling faster service delivery through automated orchestration processes.

Long-term wealth can be built through patience, reinvestment, and the compounding power of reliable dividends. You need less stress and anxiety in retirement; The Income Method can enable that for you. We discuss our top picks offering +7% Yields for powerful paychecks in retirement.

Energy stocks, as represented by a benchmark exchange-traded fund (ETF), the Energy Select Sector SPDR Fund NYSEARCA: XLE, have had a difficult first half of 2025. The sector plunged in early April on a combination of tariff uncertainty and broader geopolitical moves in the oil and gas space, and it has failed to fully recover since then.

South African Firm Commits to Driving American Industrial Renewal and Africa-U.S. Commercial Diplomacy FISHERS, IN / ACCESS Newswire / June 2, 2025 / American Resources Corporation (NASDAQ:AREC) ("American Resources"), through its holding in ReElement Technologies Corporation ("ReElement"), a leading U.S. innovator in rare earth element (REE) and critical mineral refining, announced today that Novare Holdings Proprietary Limited ("Novare"), a South African-headquartered institutional investment firm, has committed to be the anchor investor in ReElement's private capital raise. This commitment will help unlock approximately $150 million in combined equity and debt financing to expand ReElement's refining operations at its 42-acre Marion, Indiana …

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your NET Power, Inc. (NYSE:NPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/net-power-inc-lawsuit-submission-form?prid=151213&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=151214&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - EMX Royalty Corporation (NYSE American: EMX) (TSXV: EMX) (the "Company" or "EMX") is pleased to announce the sale of its Nordic operational platform to First Nordic Metals Corporation (TSXV: FNM) ("FNM"), a current partner of EMX and operator on multiple EMX royalty properties in Sweden and Finland. This strategic divestment will include EMX's infrastructure, exploration equipment and employees in the Nordic countries.

PHILADELPHIA and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today presents clinical data in three clinical poster presentations and one publish-only abstract at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. BriaCell has featured robust survival and clinical benefit data from its Bria-IMT Phase 2 clinical study, clinical progress data from its ongoing pivotal Bria-IMT Phase 3 study (ClinicalTrials.gov identifier: NCT06072612), and Phase 1/2 study of Bria-OTS (ClinicalTrials.gov identifier: NCT06471673) in metastatic …

CLEVELAND, June 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151218&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151230&wire=1&utm_campaign=7 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=151215&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Digimarc Corporation (NASDAQ:DMRC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/digimarc-corporation-lawsuit-submission-form-2?prid=151216&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=151217&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager Expect to share initial data in the first half of 2026 PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, announced today that it is presenting a Trial in Progress poster for the Phase 1 clinical trial evaluating CTIM-76 in ovarian, endometrial, and testicular cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, being held May 30 – June 3, …

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=151231&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.